A rare PANK2 deletion in the first north African patient affected with pantothenate kinase associated neurodegeneration

Affiliations

• ¹ Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
• ² Unit of Neuropediatrics and Neurometabolism, Pediatric Department 2, Rabat Children's Hospital, Morocco.
• ³ Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
• ⁴ Department of Neuroradiology, Great Ormond Street Hospital for Children, London WC1N 3JH, UK.
• ⁵ Department of Clinical and Experimental Medicine, University of Messina, Sicily, Italy.
• ⁶ Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; Center for Neurology and Hertie Institute for Clinical Brain Research, Eberhard Karls-University, Tübingen, Germany. Electronic address: s.wiethoff.12@ucl.ac.uk.